Series by David C. Helfgott, MD

A collection of news, case studies, and feature articles focused on the diagnosis and management of infectious processes in patients with immune systems impaired by an underlying disease, such as hematologic malignancies that affect cells crucial to normal host immune response, or weakened secondary to treatments for disease, such as steroids, chemotherapeutic agents, or biologic response modifiers targeting immune mediators.

Feature

Infections Complicate Biologic Use in Autoimmune Inflammatory Disorders

Infections Complicate Biologic Use in Autoimmune Inflammatory Disorders

The risk for infection and malignancy associated with biologic use complicates the management of patients with a deficient immune system. Equip yourself with the information needed to effectively manage these complex patients.

Sign Up for Free e-newsletters